Literature DB >> 31975755

Uncommon Presentations of Diabetes: Zebras in the Herd.

Karen L Shidler1, Lisa R Letourneau2, Lucia M Novak3.   

Abstract

The majority of patients with diabetes are diagnosed as having either type 1 or type 2 diabetes. However, when encountered in clinical practice, some patients may not match the classic diagnostic criteria or expected clinical presentation for either type of the disease. Latent autoimmune, ketosis-prone, and monogenic diabetes are nonclassical forms of diabetes that are often misdiagnosed as either type 1 or type 2 diabetes. Recognizing the distinguishing clinical characteristics and understanding the diagnostic criteria for each will lead to appropriate treatment, facilitate personalized medicine, and improve patient outcomes.
© 2019 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 31975755      PMCID: PMC6969666          DOI: 10.2337/cd19-0019

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


  117 in total

Review 1.  Type 1 diabetes: etiology, immunology, and therapeutic strategies.

Authors:  Tom L van Belle; Ken T Coppieters; Matthias G von Herrath
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

2.  Comprehensive genetic screening: The prevalence of maturity-onset diabetes of the young gene variants in a population-based childhood diabetes cohort.

Authors:  Stephanie R Johnson; Jonathan J Ellis; Paul J Leo; Lisa K Anderson; Uma Ganti; Jessica E Harris; Jacqueline A Curran; Aideen M McInerney-Leo; Nirubasini Paramalingam; Xiaoxia Song; Louise S Conwell; Mark Harris; Timothy W Jones; Matthew A Brown; Elizabeth A Davis; Emma L Duncan
Journal:  Pediatr Diabetes       Date:  2018-11-14       Impact factor: 4.866

Review 3.  8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

Review 4.  9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

Review 5.  6. Glycemic Targets: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

6.  Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5.

Authors:  Christine Bellanné-Chantelot; Séverine Clauin; Dominique Chauveau; Philippe Collin; Michèle Daumont; Claire Douillard; Danièle Dubois-Laforgue; Laurent Dusselier; Jean-François Gautier; Michel Jadoul; Marie Laloi-Michelin; Laetitia Jacquesson; Etienne Larger; Jacques Louis; Marc Nicolino; Jean-François Subra; Jean-Marie Wilhem; Jacques Young; Gilberto Velho; José Timsit
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

Review 7.  Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.

Authors:  Siri Atma W Greeley; Rochelle N Naylor; Louis H Philipson; Graeme I Bell
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

8.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

Authors:  Anna L Gloyn; Ewan R Pearson; Jennifer F Antcliff; Peter Proks; G Jan Bruining; Annabelle S Slingerland; Neville Howard; Shubha Srinivasan; José M C L Silva; Janne Molnes; Emma L Edghill; Timothy M Frayling; I Karen Temple; Deborah Mackay; Julian P H Shield; Zdenek Sumnik; Adrian van Rhijn; Jerry K H Wales; Penelope Clark; Shaun Gorman; Javier Aisenberg; Sian Ellard; Pål R Njølstad; Frances M Ashcroft; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

9.  Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.

Authors:  Catherine Pihoker; Lisa K Gilliam; Sian Ellard; Dana Dabelea; Cralen Davis; Lawrence M Dolan; Carla J Greenbaum; Giuseppina Imperatore; Jean M Lawrence; Santica M Marcovina; Elizabeth Mayer-Davis; Beatriz L Rodriguez; Andrea K Steck; Desmond E Williams; Andrew T Hattersley
Journal:  J Clin Endocrinol Metab       Date:  2013-06-14       Impact factor: 5.958

10.  Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.

Authors:  Tarig Babiker; Natascia Vedovato; Kashyap Patel; Nicholas Thomas; Roisin Finn; Roope Männikkö; Ali J Chakera; Sarah E Flanagan; Maggie H Shepherd; Sian Ellard; Frances M Ashcroft; Andrew T Hattersley
Journal:  Diabetologia       Date:  2016-03-31       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.